<bill session="116" type="h" number="1478" updated="2022-11-01T17:03:31Z">
  <state datetime="2019-02-28">REFERRED</state>
  <status>
    <introduced datetime="2019-02-28"/>
  </status>
  <introduced datetime="2019-02-28"/>
  <titles>
    <title type="display">Affordable Insulin Act of 2019</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to allow for the importation of affordable and safe insulin by wholesale distributors, pharmacies, and individuals.</title>
    <title type="short" as="introduced">Affordable Insulin Act of 2019</title>
  </titles>
  <sponsor bioguide_id="W000800"/>
  <cosponsors>
    <cosponsor bioguide_id="R000607" joined="2019-02-28"/>
  </cosponsors>
  <actions>
    <action datetime="2019-02-28">
      <text>Introduced in House</text>
    </action>
    <action datetime="2019-02-28" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2019-03-01">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="116" type="s" number="97" relation="unknown"/>
    <bill session="116" type="s" number="1801" relation="unknown"/>
    <bill session="116" type="h" number="447" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Administrative law and regulatory procedures"/>
    <term name="Canada"/>
    <term name="Congressional oversight"/>
    <term name="Department of Health and Human Services"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Prescription drugs"/>
    <term name="Trade restrictions"/>
    <term name="User charges and fees"/>
  </subjects>
  <amendments/>
  <summary date="2021-09-12T14:58:48Z" status="Introduced in House">Affordable Insulin Act of 2019

This bill addresses the importation of insulin from Canada and other foreign countries.

The bill requires the Food and Drug Administration (FDA) to promulgate regulations within 180 days permitting wholesalers, pharmacies, and individuals to import certain insulin from Canada. The FDA may also permit the importation of insulin from certain other countries under specified circumstances.

The bill also establishes a process for certifying licensed foreign pharmacies and foreign wholesale distributors.</summary>
</bill>
